Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$235.67 +2.66 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Price to Earnings (2011 - 2026)

Updated

Jazz Pharmaceuticals' (JAZZ) Price to Earnings came in at 16.63 for Q2 2026, down 95.9% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Price to Earnings (2011 - 2026) Analysis & Trends

For FY2024, Jazz Pharmaceuticals' Price to Earnings stood at 13.33, down 27.8% from FY2023.

  • In prior years, Jazz Pharmaceuticals' Price to Earnings was 18.46 in FY2023 and 38.85 in FY2020 (+142.6%).
  • The Q2 2026 figure stands as the lowest quarterly Price to Earnings since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Jazz Pharmaceuticals 15.30 Bn 9.12 Bn 1.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.63
Mar 31, 2026 402.59
Mar 31, 2025 15.87
Dec 31, 2024 13.33
Sep 30, 2024 14.54
Jun 30, 2024 16.69
Mar 31, 2024 22.95
Dec 31, 2023 18.46
Sep 30, 2023 101.92
Jun 30, 2021 270.45
Mar 31, 2021 18.04
Dec 31, 2020 38.85
Sep 30, 2020 44.33
Jun 30, 2020 45.93
Mar 31, 2020 19.69
Dec 31, 2019 16.01
Sep 30, 2019 11.91
Jun 30, 2019 12.31
Mar 31, 2019 16.66
Dec 31, 2018 15.94
API Access

Jazz Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=JAZZ&period=max&api_key=YOUR_API_KEY